| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/11/2001 | US6329148 Contacting a susceptible tumor cell with a synergistic combination of a death domain receptor ligand; and a diterpenoid triepoxide for enhanced killing of tumor cells |
| 12/11/2001 | US6329011 Alpha-type thionin and a beta-type thionin as fruit juice preservatives |
| 12/11/2001 | US6328996 Polypeptide capable of contacted state and relaxed state |
| 12/11/2001 | US6328978 Methods for the treatment of immunologically-mediated skin disorders |
| 12/11/2001 | US6328977 With neurotoxin |
| 12/11/2001 | US6328971 MAGE-1 derived nona peptides, and compositions thereof |
| 12/11/2001 | US6328968 Organ transplant |
| 12/11/2001 | US6328966 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 12/11/2001 | US6328964 Method to treat multiple sclerosis with GP39-specific antibodies |
| 12/11/2001 | US6328958 Deleted adenovirus vectors and methods of making and administering the same |
| 12/11/2001 | US6328957 Heat shock proteins and the treatment of tumors |
| 12/11/2001 | US6328956 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 12/11/2001 | US6328955 Method for regulating IL-10 with IL-9, and applications thereof |
| 12/11/2001 | US6328954 Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections |
| 12/11/2001 | US6328765 Methods and articles for regenerating living tissue |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2300703C Method for treating excessive sweating |
| 12/11/2001 | CA2300464C Method for treating headache |
| 12/11/2001 | CA2215234C Composition containing amlodipine, or its salt and an ace inhibitor |
| 12/11/2001 | CA2151741C Methods of producing analgesia and enhancing opiate analgesia |
| 12/11/2001 | CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same |
| 12/11/2001 | CA2066053C Recombinant retroviruses delivering vector constructs to target cells |
| 12/11/2001 | CA2063883C Long-acting biodegradable microparticles and a process for their preparation |
| 12/11/2001 | CA2050477C T cell growth factor |
| 12/08/2001 | CA2347316A1 Growth promoting pharmaceutical implant |
| 12/06/2001 | WO2001093170A1 Method and system for foreign exchange price procurement and automated hedging |
| 12/06/2001 | WO2001092892A2 Methods to identify compounds that modulate rage |
| 12/06/2001 | WO2001092891A2 Regulating lipid levels via the zmax1 or hbm gene |
| 12/06/2001 | WO2001092584A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 12/06/2001 | WO2001092581A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | WO2001092580A2 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | WO2001092567A2 Novel target genes for diseases of the heart |
| 12/06/2001 | WO2001092551A2 Duplexed parvovirus vectors |
| 12/06/2001 | WO2001092540A1 Novel polypeptide - a human stat2 protein 11 and polynucleotide encoding it |
| 12/06/2001 | WO2001092532A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | WO2001092524A2 Myosin-like gene expressed in human heart and muscle |
| 12/06/2001 | WO2001092523A2 Human polynucleotides and polypeptides encoded thereby |
| 12/06/2001 | WO2001092522A2 Human fgf-20 nucleic acids and polypeptides |
| 12/06/2001 | WO2001092519A1 A novel polypeptide, a dynein light-moderate chain 20 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092518A1 A novel polypeptide, a human ccr4 relative protein 9.5 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092517A1 A novel polypeptide, a human transformer-2-beta protein 29.15 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092515A1 A novel polypeptide, a human transcription factor 29.26 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092512A2 Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
| 12/06/2001 | WO2001092499A1 NUCLEIC ACID MOLECULES ENCODING A PROTEIN INTERACTING WITH Ser/Thr KINASE Akt |
| 12/06/2001 | WO2001092497A2 Human pancreatic islet glucose-6-phosphatase |
| 12/06/2001 | WO2001092492A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092491A2 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | WO2001092490A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 12/06/2001 | WO2001092488A2 Regulation of human plc delta-1 |
| 12/06/2001 | WO2001092484A2 Adjuvant preparation for the induction of specific immunity |
| 12/06/2001 | WO2001092474A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | WO2001092340A2 Use of interleukin-4 antagonists and compositions thereof |
| 12/06/2001 | WO2001092339A1 Molecular marker for mitosis |
| 12/06/2001 | WO2001092337A2 Soluble ctla4 mutant molecules and uses thereof |
| 12/06/2001 | WO2001092336A1 Lactoferrin polypeptides from h. pylori and vaccine compositions thereof |
| 12/06/2001 | WO2001092334A1 Glucose dependent release of insulin from glucose sensing insulin derivatives |
| 12/06/2001 | WO2001092333A2 Use of adnf for enhancing learning and memory |
| 12/06/2001 | WO2001092332A1 Feline hepatocyte growth factor |
| 12/06/2001 | WO2001092331A2 Compositions and methods for the treatment of immune related diseases |
| 12/06/2001 | WO2001092330A2 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 12/06/2001 | WO2001092325A1 A novel polypeptide human-zinc-finger protein 13 and a polynucleotide encoding the same |
| 12/06/2001 | WO2001092323A1 A novel polypeptide - human class ii aminoacyl-trna synthetase 17 and a polynucleotide encoding the same |
| 12/06/2001 | WO2001092322A1 Use of collagen of aquatic origin for producing support designed for tissue engineering, and resulting supports and biomaterials |
| 12/06/2001 | WO2001092320A2 Use a high-molecular-weight extracellular haemoglobin as blood substitute |
| 12/06/2001 | WO2001092319A1 A NOVEL POLYPEPTIDE-HOMO TNF α RECEPTOR 19.68 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 12/06/2001 | WO2001092318A1 A novel polypeptide, a kringle protein 14 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092317A1 A novel polypeptide homo peroxidase 9 and polynucleotide encoding said polypeptide |
| 12/06/2001 | WO2001092316A1 A novel polypeptide, a phytochrome 12 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092314A1 A novel polypeptide, a human organic anion transporting polypeptide 10 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092309A2 Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092307A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092306A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092305A2 Mammalian transforming growth factor beta-10 |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092303A2 Human ion channels |
| 12/06/2001 | WO2001092302A2 Human cyslt2 nucleic acids, polypeptides, and uses thereof |
| 12/06/2001 | WO2001092301A2 Placc, a novel human c-c chemokine isolated from placenta |
| 12/06/2001 | WO2001092299A2 Adenovirus particles with mutagenized fiber proteins |
| 12/06/2001 | WO2001092297A2 Regulation of human lgr4-like g protein-coupled receptor |
| 12/06/2001 | WO2001092296A2 Regulation of human isotocin-like g protein-coupled receptor |
| 12/06/2001 | WO2001092295A2 Ligands for cd21 and compositions thereof for modulating immune responses |
| 12/06/2001 | WO2001092294A2 Therapeutic anti-melanoma compounds |
| 12/06/2001 | WO2001092292A2 Ghrelin analogs |
| 12/06/2001 | WO2001092290A2 Ganesin, an 18-residue cysteine-rich defense peptide from spider and related antinicrobial papdides, their preparation and uses. |
| 12/06/2001 | WO2001092211A1 Compounds exhibiting thrombopoietin-like activities |
| 12/06/2001 | WO2001091814A2 Polyubiquitin based hydrogel and uses thereof |
| 12/06/2001 | WO2001091808A2 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 12/06/2001 | WO2001091805A2 Compounds for targeting endothelial cells |
| 12/06/2001 | WO2001091803A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 12/06/2001 | WO2001091801A2 Methods of transducing neural cells using lentivirus vectors |
| 12/06/2001 | WO2001091789A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 12/06/2001 | WO2001091785A2 Use of hyaluronidase for preventing and treating cardio vascular diseases |
| 12/06/2001 | WO2001091784A1 Means for maintenance and/or correction of glucose concentration in blood |
| 12/06/2001 | WO2001091783A2 Methods and compositions for producing a neurosalutary effect in a subject |
| 12/06/2001 | WO2001091782A1 Pralmorelin-containing nasal drop preparations |
| 12/06/2001 | WO2001091781A2 Thrombospondin type 1 repeat polypeptides |